IP Library Granted Patent US 7,601,822
Granted Patent B2
US 7,601,822 · App. 10/529,319 · Granted Oct 13, 2009

Molecular identification of bacteria of genus

Assignees: Universite de la Mediterranee (AIX-Marsille II); Centre National de la Recherche Scientifque (CNRS)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,601,822
App. No.
10/529,319
Granted
Oct 13, 2009
Kind
B2
Abstract

The invention concerns a method for detecting by molecular identification a bacterium of one of the species of genus Streptococcus and four related genera Enterococcus, Gemella, Abiotrophia and Granulicatella which consists of using as probe or primer: the rpoB gene or gene fragment of one said bacterium of sequences SEQ ID no 1 to 3, or an oligonucleotide or mixture of oligonucleotides derived from sequences SEQ ID no 8 to 35, or in particular the oligonucleotides of sequences SEQ ID no 6 and 7.

Claims (63)

1. An isolated rpoB gene or gene fragment of a bacterium of the genus Streptococcus or the related genus Enterococcus , comprising a nucleic acid sequence selected from the group consisting of:

a. SEQ ID NOs: 8-10, 13, 15, 16, 20, 24, 29, and 30; and

b. the full-length complementary sequences of the nucleic acid sequences of (a).

2. An isolated rpoB gene of claim 1 wherein the bacterium is of the bacteria Streptococcus anginosus , comprising a nucleic acid sequence selected from the group consisting of:

a. SEQ ID NO:1 wherein:

K nucleotide represents T or G,

M nucleotide represents A or C,

R nucleotide represents A or G,

W nucleotide represents A or T,

Y nucleotide represents C or T, and

N nucleotide represents A, T, C, G or I; and

b. the full-length complementary sequences of the nucleic acid sequences of (a).

3. A mixture of oligonucleotides, comprising:

an equimolar mixture of oligonucleotides, wherein each oligonucleotide in the equimolar mixture of oligonucleotides has a different sequence and comprises at least 15 consecutive nucleotides of the full-length sequence set forth in SEQ ID NO:6 or SEQ ID NO:7, or at least 15 consecutive nucleotides of the full-length complementary sequences thereof, where:

N represents, for the equimolar mixture, inosine or N represents, for the equimolar mixture, equimolar amounts of A, T, C, and G,

R represents A or G,

M represents A or C, and

Y represents C or T.

4. A mixture of oligonucleotides according to claim 3 , wherein the equimolar mixture of oligonucleotides comprises 32 different oligonucleotides, wherein each oligonucleotide in the equimolar mixture of oligonucleotides comprises at least 15 consecutive nucleotides of the sequence set forth in SEQ ID NO:6, or at least 15 consecutive nucleotides of the full-length complementary sequence thereof, where:

R represents A or G,

Y represents C or T,

M represents A or C, and

N represents A, T, C or G.

5. A mixture of oligonucleotides according to claim 3 , wherein the equimolar mixture of oligonucleotides comprises 8 different oligonucleotides, wherein each oligonucleotide in the equimolar mixture of oligonucleotides comprises at least 15 consecutive nucleotides of the sequence set forth in SEQ ID NO:6, or at least 15 consecutive nucleotides of the full-length complementary sequence thereof, where:

R represents A or G,

Y represents C or T,

M represents A or C, and

N represents inosine.

6. A mixture of oligonucleotides according to claim 3 , wherein the equimolar mixture of oligonucleotides comprises 16 different oligonucleotides, wherein each oligonucleotide in the equimolar mixture of oligonucleotides comprises at least 15 consecutive nucleotides of the sequence set forth in SEQ ID NO:7, or at least 15 consecutive nucleotides of the full-length complementary sequence thereof, where:

R represents A or G, and

N represents A, T, C or G.

7. A mixture of oligonucleotides according to claim 3 , wherein the equimolar mixture of oligonucleotides comprises 4 different oligonucleotides, wherein each oligonucleotide in the equimolar mixture of oligonucleotides comprises at least 15 consecutive nucleotides of the sequence set forth in SEQ ID NO:7, or at least 15 consecutive nucleotides of the full-length complementary sequence thereof, where:

R represents A or G, and

N represents inosine.

8. A mixture of oligonucleotides according to claim 3 , wherein each oligonucleotide in the equimolar mixture of oligonucleotides consists of the sequence set forth in SEQ ID NO:6, SEQ ID NO:7, or the full-length complementary sequences thereof.

9. A method for detecting the presence of a bacterium of genus Streptococcus or of 4 related genera Enterococcus, Gemella, Abiotrophia and Granulicatella , comprising:

1. contacting at least one genus probe comprising a mixture of oligonucleotides as in claim 3 , with a sample containing or possibly containing nucleic acids of at least one said bacterium, and

2. determining the formation or non-formation of a hybridization complex between said genus probe and nucleic acids of the specimen, wherein the presence of said bacterium in the specimen is indicated by formation of a hybridization complex.

10. A method for detecting the presence of a bacterium of genus Streptococcus or of 4 related genera Enterococcus, Gemella, Abiotrophia and Granulicatella , comprising:

1. contacting amplification primers comprising mixtures of oligonucleotides as in claim 7 , with a sample containing or possibly containing nucleic acids of at least one said bacterium, wherein:

a 5′ primer comprises an equimolar mixture of oligonucleotides, wherein each oligonucleotide in the equimolar mixture of oligonucleotides has a different sequence and comprises at least 15 consecutive nucleotides of the sequence set forth in SEQ ID NO:6, or at least 15 consecutive nucleotides of the full-length complementary sequence thereof, and

a 3′ primer comprises an equimolar mixture of oligonucleotides, wherein each oligonucleotide in the equimolar mixture of oligonucleotides has a different sequence and comprises at least 15 consecutive nucleotides of the sequence set forth in SEQ ID NO:7, or at least 15 consecutive nucleotides of the full-length complementary sequence thereof; and

2. amplifying nucleic acids by enzymatic polymerization reaction to determine the presence or absence of an amplification product, wherein occurrence of an amplification product indicates the presence of said bacterium in the sample.

11. A method for detecting whether a given species of a bacterium of genus Streptococcus or related genera is present in a sample, said given species of a bacterium selected from the group of species consisting of:

Streptococcus mutans, Streptococcus oralis, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus salivarius, Streptococcus sanguinis, Streptococcus suis, Streptococcus acidominimus, Streptococcus agalactiae, Streptococcus anginosus, Streptococcus constellatus, Streptococcus difficilis, Streptococcus dysgalactiae, Streptococcus equi, Streptococcus equinus, Streptococcus intermedius, Streptococcus mitis, Streptococcus bovis, Streptococcus alactolyticus, Streptococcus gallolyticus, Streptococcus macedonicus, Streptococcus infantarius, Streptococcus hominis, Granulicatella adjacens, Abiotrophia defectiva, Enterococcus avium, Enterococcus casselliflavus, Enterococcus faecalis, Enterococcusfaecium, Enterococcus gallinarum, Enterococcus sacharolyticus, Gemella haemolysans , and Gemella morbillorum , the method comprising:

a) sequencing an amplified rpoB gene fragment of a bacterium using nucleotide primers comprising said oligonucleotide mixtures as in claim 3 , wherein:

a 5′ primer comprises an equimolar mixture of oligonucleotides, wherein each oligonucleotide in the equimolar mixture of oligonucleotides has a different sequence and comprises at least 15 consecutive nucleotides of the sequence set forth in SEQ ID NO:6, or at least 15 consecutive nucleotides of the full-length complementary sequence thereof, and

a 3′ primer comprises an equimolar mixture of oligonucleotides, wherein each oligonucleotide in the equimolar mixture of oligonucleotides has a different sequence and comprises at least 15 consecutive nucleotides of the sequence set forth in SEQ ID NO:7, or at least 15 consecutive nucleotides of the full-length complementary sequence thereof; and

b) determining the presence or absence of the given species of said bacterium by comparing the sequence obtained of said fragment with the sequence of the complete rpoB gene of said bacterium or the sequence of a rpoB gene fragment of said bacterium respectively comprising said sequences selected from the group consisting of:

i) SEQ ID NOs:8-35; and

ii) the full-length complementary sequences of the nucleic acid sequences of (i);

wherein the presence of said bacterium in the sample is determined if the obtained sequence of said fragment is identical to the known sequence of the rpoB gene or gene fragment of said bacterium.

12. The method according to claim 10 , further comprising:

3. determining whether at least one species selected from the group consisting of Streptococcus mutans, Streptococcus oralis, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus salivarius, Streptococcus sanguinis, Streptococcus suis, Streptococcus acidominimus, Streptococcus agalactiae, Streptococcus anginosus, Streptococcus constellatus, Streptococcus difficilis, Streptococcus dysgalactiae, Streptococcus equi, Streptococcus equinus, Streptococcus intermedius, Streptococcus mitis, Streptococcus bovis, Streptococcus alactolyticus, Streptococcus gallolyticus, Streptococcus macedonicus, Streptococcus infantarius, Streptococcus hominis, Granulicatella adjacens, Abiotrophia defectiva, Enterococcus avium, Enterococcus casselliflavus, Enterococcus faecalis, Enterococcus faecium, Enterococcus gallinarum, Enterococcus sacharolyticus, Gemella haemolysans , and Gemella morbillorum , is present in the sample by contacting the amplification product with at least one species probe comprising a nucleic acid sequence selected from the group consisting of:

(a) the sequences set forth in SEQ ID NOs:8-35; and

(b) the full-length complementary sequences of the nucleic acid sequences of (a); and

4. determining formation or non-formation of a hybridization complex between said species probe and the amplification product, wherein the formation of a hybridization complex indicates the presence of said at least one species in the sample.

13. A set of isolated rpoB gene or gene fragments comprising different rpoB gene or gene fragments respectively comprising:

(a) the full-length sequences set forth in SEQ ID NOs:8-35; or

(b) the full-length complementary sequences of the sequences of (a).

14. A set of isolated rpoB gene or gene fragments comprising different rpoB gene or gene fragments respectively comprising:

(a) the full-length sequences set forth in SEQ ID NOs:8-35; and

(b) the full-length complementary sequences of the sequences of (a).

Assignments (3)
MERGER Recorded Feb 19, 2014
From: UNIVERSITE DE PROVENCE; UNIVERSITE DE LA MEDITERRANEE; UNIVERSITE PAUL CEZANNE
To: UNIVERSITE D'AIX-MARSEILLE
Reel/Frame 032245/0412 →
MERGER Recorded Jan 8, 2014
From: UNIVERSITE DE LA MEDITERRANEE
To: UNIVERSITE D'AIX-MARSEILLE
Reel/Frame 031914/0282 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2005
From: DRANCOURT, MICHEL; RAOULT, DIDIER
To: UNIVERSITE DE LA MEDITERRANEE (AIX-MARSEILLE II); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
Reel/Frame 017464/0372 →
Priority Claims (1)
FR 02 13792 · Nov 5, 2002 · national
Continuity (1)
Related Publication 20060199182A1 · Sep 7, 2006